An ImmunoModulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis IMMUNOMODULATION SARM

Description

An Immunomodulatory Formulation consisting of Nf-Kappa B , TNF-A and IL-6 Suppressive Protopanaxatriol Class Glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration , A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement , via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis.

Inventors : Erdal Can ALKOCLAR

Metehan YESIl

Producer

Latest update

April 23, 2020

License

Creative Commons Attribution 4.0

Metadata quality
56.0%

Update frequency not followed

File formats are closed

Temporal coverage not set

Spatial coverage not set

There are no reuses for this dataset yet.

Publish a reuse What's a reuse ?

There are no discussions for this dataset yet.

There are no community resources for this dataset yet.

Share your resources Learn more about the community

Information

Temporality

Creation

April 23, 2020

Frequency

Annual

Latest update

April 23, 2020

Actions

Embed